What is the oral (per os) dosing regimen for labetalol?

Oral Labetalol Dosing

For chronic hypertension management, start labetalol at 100 mg twice daily and titrate upward every 2-3 days by 100 mg twice daily increments until blood pressure is controlled, up to a maximum of 2400 mg/day in divided doses. 1

Initial Dosing

• Starting dose: 100 mg twice daily (BID)
• Peak effect: 2-4 hours after administration
• Duration of action: 8-12 hours depending on dose (at least 8 hours with 100 mg, >12 hours with 300 mg)
• Steady state: Achieved by day 3 of dosing 1

Titration Schedule

Increase by 100 mg BID every 2-3 days based on blood pressure response:

• Most patients respond to 200-400 mg BID
• Maximum dose: 1200 mg BID (2400 mg/day total)
• Optimal therapeutic range for most patients: 200-800 mg/day in 2 divided doses 1

Clinical Context-Specific Dosing

Hypertensive Urgency (Emergency Department)

For acute blood pressure reduction in patients with diastolic BP 110-140 mmHg without end-organ damage:

• Single oral dose: 100-300 mg
• Response rate: 58-75% achieve diastolic BP ≤100 mmHg or ≥30 mmHg reduction within 2 hours
• Duration: Effect maintained for 4+ hours 2

Severe Hypertension (Diastolic ≥130 mmHg)

• Initial dose: 400 mg orally
• Repeat dosing: Additional doses at 2,6,12,18, and 24 hours as needed based on BP response
• Expected response: Mean BP reduction from 241/130 to 157/103 mmHg within 6 hours 3

Pregnancy-Related Hypertension

Labetalol is a preferred agent for hypertensive emergencies in pregnancy:

• Acute treatment: 10-20 mg IV over 1-2 minutes, may repeat every 10-30 minutes up to 300 mg cumulative dose
• Maintenance (oral): After IV stabilization, transition to 200-600 mg BID 4, 5

Important Clinical Considerations

Pharmacokinetics

• Bioavailability: 25% (due to extensive first-pass metabolism)
• Increased with food: Take consistently with or without meals
• Half-life: 6-8 hours
• Protein binding: 50% 1

Contraindications

• Absolute: Reactive airway disease, COPD, decompensated heart failure, second- or third-degree heart block, bradycardia 6, 7, 6
• Caution: Hepatic impairment (increased bioavailability due to reduced first-pass metabolism) 1

Monitoring

• Postural hypotension risk: Most likely 2-4 hours post-dose, especially with large initial doses or rapid titration
• Blood pressure: Check supine and standing BP during titration
• Heart rate: Monitor for bradycardia (target resting HR 50-60 bpm is acceptable) 8, 1

Common Pitfalls

1. Starting too high: Begin at 100 mg BID, not higher doses, to minimize postural hypotension risk
2. Titrating too quickly: Allow 2-3 days between dose increases to assess response
3. Abrupt discontinuation: Taper gradually to avoid rebound hypertension, especially in patients with coronary artery disease 1

Special Populations

• Elderly: May initiate at standard 100 mg BID dose, but elimination may be reduced; monitor closely 1
• Hepatic impairment: Start at lower end of dosing range; bioavailability is increased 1
• Renal impairment: No dose adjustment needed; elimination half-life unchanged 1